{
    "Trade/Device Name(s)": [
        "Gentian Cystatin C Immunoassay"
    ],
    "Submitter Information": "Gentian AS",
    "510(k) Number": "K081875",
    "Predicate Device Reference 510(k) Number(s)": [
        "K071388"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NDY"
    ],
    "Summary Letter Date": "July 24, 2008",
    "Summary Letter Received Date": "July 25, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1225"
    ],
    "Regulation Name(s)": [
        "Creatinine Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cystatin C"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Lithium Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Beckman Coulter Synchron",
        "Beckman Coulter UniCel"
    ],
    "Method(s)/Technology(ies)": [
        "Particle Enhanced Turbidimetric Immunoassay (PETIA)"
    ],
    "Methodologies": [
        "Immunoassay",
        "Turbidimetry"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Gentian Cystatin C Immunoassay using PETIA on Beckman Coulter Synchron and UniCel systems for measurement of cystatin C in serum and plasma.",
    "Indications for Use Summary": "In vitro diagnostic test for quantitative determination of cystatin C in human serum and plasma to aid in the diagnosis and treatment of renal diseases.",
    "fda_folder": "Clinical Chemistry"
}